Speaker Bio
Jeff Davis advises health care organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the federal 340B drug pricing program. He also counsels clients on emerging health care regulatory issues, including COVID-19 relief funding, surprise medical billing, and hospital price transparency, and he provides strategic insights to clients on public policy matters under consideration by the U.S. Congress and federal agencies, such as drug pricing policy and nonprofit hospital issues. He forged his deep knowledge of the 340B program and other Medicare and Medicaid reimbursement issues while working in the federal public policy arena. He spent more than seven years as vice president and legislative and policy counsel for 340B Health, an association of more than 1,500 hospitals and health systems participating in the 340B program. In this role, he provided technical assistance to member hospitals, directed research and policy efforts, and helped lead government relations efforts to educate federal policymakers on 340B issues. He draws on this experience to advise hospitals, pharmacies, other provider organizations, and vendors on 340B issues including enrollment, contracting, audits, compliance, and self-disclosures. Before his work at 340B Health, he was the health care legislative assistant to U.S. Rep. Shelley Berkley (D-Nev.), where he worked with health care provider companies to promote increased Medicare funding for a range of organizations, including hospitals, physicians, and post-acute providers. He is a frequent speaker on the 340B program for conferences and webinars organized by the American Health Law Association, the 340B Coalition, other national provider groups, and state hospital associations.